Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Zusman

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Hypertension (Dallas, Tex. : 1979)|September 1, 1988
In defense of alternative antihypertensive therapyR M Zusman
Clinical Research|April 1, 1989
On the occasion of the fiftieth anniversary of the founding of the American Federation for Clinical Research. A look to the futureR M Zusman
American Journal of Hypertension|June 1, 1989
Left ventricular function in hypertension. Relevance to the selection of antihypertensive therapyR M Zusman
Managed Care (Langhorne, Pa.)|December 4, 2001
Antiplatelet therapy: a perspective from cardiologyR M Zusman
Managed Care (Langhorne, Pa.)|December 4, 2001
Clinical and economic implications of atherosclerosisR M Zusman
The Medical Clinics of North America|July 1, 1981
Prostaglandins, vasopressin, and renal water reabsorptionR M Zusman
The American Journal of Cardiology|March 17, 1999
Cardiovascular data on sildenafil citrate: introductionR M Zusman
Managed Care (Langhorne, Pa.)|December 4, 2001
Clinical and economic implications of atherosclerosisR M Zusman
Hypertension (Dallas, Tex. : 1979)|May 1, 1989
Alternatives to traditional first-line antihypertensive treatment: unresolved questions and therapeutic dilemmas. A personal approachR M Zusman
Kidney International|March 1, 1980
Regulation of prostaglandin E2 synthesis by angiotensin II, potassium, osmolality, and dexamethasoneR M Zusman, H R Keiser
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Hypertension (Dallas, Tex. : 1979)|September 1, 1988
In defense of alternative antihypertensive therapyR M Zusman
Clinical Research|April 1, 1989
On the occasion of the fiftieth anniversary of the founding of the American Federation for Clinical Research. A look to the futureR M Zusman
American Journal of Hypertension|June 1, 1989
Left ventricular function in hypertension. Relevance to the selection of antihypertensive therapyR M Zusman
Managed Care (Langhorne, Pa.)|December 4, 2001
Antiplatelet therapy: a perspective from cardiologyR M Zusman
Managed Care (Langhorne, Pa.)|December 4, 2001
Clinical and economic implications of atherosclerosisR M Zusman
The Medical Clinics of North America|July 1, 1981
Prostaglandins, vasopressin, and renal water reabsorptionR M Zusman
The American Journal of Cardiology|March 17, 1999
Cardiovascular data on sildenafil citrate: introductionR M Zusman
Managed Care (Langhorne, Pa.)|December 4, 2001
Clinical and economic implications of atherosclerosisR M Zusman
Hypertension (Dallas, Tex. : 1979)|May 1, 1989
Alternatives to traditional first-line antihypertensive treatment: unresolved questions and therapeutic dilemmas. A personal approachR M Zusman
Kidney International|March 1, 1980
Regulation of prostaglandin E2 synthesis by angiotensin II, potassium, osmolality, and dexamethasoneR M Zusman, H R Keiser
Pageof 8